vs
IRONWOOD PHARMACEUTICALS INC(IRWD)与REGIS CORP(RGS)财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.2倍($57.1M vs $47.7M),REGIS CORP净利率更高(0.8% vs -4.8%,领先5.6%),REGIS CORP同比增速更快(22.3% vs -47.3%),IRONWOOD PHARMACEUTICALS INC自由现金流更多($74.6M vs $891.0K),过去两年REGIS CORP的营收复合增速更高(7.8% vs -20.2%)
Ironwood制药公司是一家上市制药企业,其前身为Microbia公司,专注于制药领域相关业务研发与运营,面向市场开发各类创新医药产品,满足未被充分满足的临床医疗需求。
瑞吉斯公司是一家美国美发沙龙运营商,总部位于明尼苏达州明尼阿波利斯市。截至2021年8月,该集团旗下拥有5563家加盟沙龙以及276家直营门店,是北美地区规模领先的美发沙龙连锁经营企业。
IRWD vs RGS — 直观对比
营收规模更大
RGS
是对方的1.2倍
$47.7M
营收增速更快
RGS
高出69.6%
-47.3%
净利率更高
RGS
高出5.6%
-4.8%
自由现金流更多
IRWD
多$73.7M
$891.0K
两年增速更快
RGS
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $47.7M | $57.1M |
| 净利润 | $-2.3M | $456.0K |
| 毛利率 | — | — |
| 营业利润率 | 14.3% | 10.8% |
| 净利率 | -4.8% | 0.8% |
| 营收同比 | -47.3% | 22.3% |
| 净利润同比 | -200.9% | -94.0% |
| 每股收益(稀释后) | $0.01 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IRWD
RGS
| Q4 25 | $47.7M | $57.1M | ||
| Q3 25 | $122.1M | $59.0M | ||
| Q2 25 | $85.2M | $60.4M | ||
| Q1 25 | $41.1M | $57.0M | ||
| Q4 24 | $90.5M | $46.7M | ||
| Q3 24 | $91.6M | $46.1M | ||
| Q2 24 | $94.4M | $49.4M | ||
| Q1 24 | $74.9M | $49.2M |
净利润
IRWD
RGS
| Q4 25 | $-2.3M | $456.0K | ||
| Q3 25 | $40.1M | $1.4M | ||
| Q2 25 | $23.6M | $116.5M | ||
| Q1 25 | $-37.4M | $250.0K | ||
| Q4 24 | $2.3M | $7.6M | ||
| Q3 24 | $3.6M | $-853.0K | ||
| Q2 24 | $-860.0K | $91.2M | ||
| Q1 24 | $-4.2M | $-2.3M |
营业利润率
IRWD
RGS
| Q4 25 | 14.3% | 10.8% | ||
| Q3 25 | 61.8% | 10.0% | ||
| Q2 25 | 53.2% | 12.1% | ||
| Q1 25 | -70.7% | 8.8% | ||
| Q4 24 | 34.8% | 11.8% | ||
| Q3 24 | 28.0% | 4.6% | ||
| Q2 24 | 26.5% | — | ||
| Q1 24 | 14.7% | 8.3% |
净利率
IRWD
RGS
| Q4 25 | -4.8% | 0.8% | ||
| Q3 25 | 32.8% | 2.3% | ||
| Q2 25 | 27.7% | 192.9% | ||
| Q1 25 | -90.9% | 0.4% | ||
| Q4 24 | 2.5% | 16.4% | ||
| Q3 24 | 4.0% | -1.9% | ||
| Q2 24 | -0.9% | 184.7% | ||
| Q1 24 | -5.6% | -4.7% |
每股收益(稀释后)
IRWD
RGS
| Q4 25 | $0.01 | $0.16 | ||
| Q3 25 | $0.23 | $0.49 | ||
| Q2 25 | $0.14 | $43.67 | ||
| Q1 25 | $-0.23 | $0.08 | ||
| Q4 24 | $0.03 | $2.71 | ||
| Q3 24 | $0.02 | $-0.36 | ||
| Q2 24 | $-0.01 | $38.40 | ||
| Q1 24 | $-0.03 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $-261.8M | $188.7M |
| 总资产 | $396.9M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势,按日历期对齐
现金及短期投资
IRWD
RGS
| Q4 25 | $215.5M | $18.4M | ||
| Q3 25 | $140.4M | $16.6M | ||
| Q2 25 | $92.9M | $17.0M | ||
| Q1 25 | $108.5M | $13.3M | ||
| Q4 24 | $88.6M | $10.2M | ||
| Q3 24 | $88.2M | $6.3M | ||
| Q2 24 | $105.5M | $10.1M | ||
| Q1 24 | $121.5M | $5.9M |
总债务
IRWD
RGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | $199.5M | $111.3M | ||
| Q2 25 | $199.3M | $110.8M | ||
| Q1 25 | $199.2M | $112.0M | ||
| Q4 24 | $199.0M | $111.5M | ||
| Q3 24 | $198.8M | $95.2M | ||
| Q2 24 | $198.6M | $99.5M | ||
| Q1 24 | $398.3M | $179.7M |
股东权益
IRWD
RGS
| Q4 25 | $-261.8M | $188.7M | ||
| Q3 25 | $-264.2M | $187.6M | ||
| Q2 25 | $-308.2M | $185.6M | ||
| Q1 25 | $-334.1M | $68.6M | ||
| Q4 24 | $-301.3M | $66.7M | ||
| Q3 24 | $-311.3M | $56.4M | ||
| Q2 24 | $-321.7M | $56.8M | ||
| Q1 24 | $-330.5M | $-35.8M |
总资产
IRWD
RGS
| Q4 25 | $396.9M | $588.3M | ||
| Q3 25 | $396.1M | $592.1M | ||
| Q2 25 | $342.9M | $599.0M | ||
| Q1 25 | $327.2M | $511.2M | ||
| Q4 24 | $350.9M | $530.1M | ||
| Q3 24 | $389.5M | $508.9M | ||
| Q2 24 | $395.6M | $530.5M | ||
| Q1 24 | $438.8M | $543.7M |
负债/权益比
IRWD
RGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $74.6M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $74.6M | $891.0K |
| 自由现金流率自由现金流/营收 | 156.3% | 1.6% |
| 资本支出强度资本支出/营收 | 0.0% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $127.0M | $14.9M |
8季度趋势,按日历期对齐
经营现金流
IRWD
RGS
| Q4 25 | $74.6M | $1.7M | ||
| Q3 25 | $47.6M | $2.3M | ||
| Q2 25 | $-15.1M | $6.8M | ||
| Q1 25 | $20.0M | $6.2M | ||
| Q4 24 | $15.2M | $2.1M | ||
| Q3 24 | $9.9M | $-1.3M | ||
| Q2 24 | $33.5M | $5.1M | ||
| Q1 24 | $45.0M | $-277.0K |
自由现金流
IRWD
RGS
| Q4 25 | $74.6M | $891.0K | ||
| Q3 25 | $47.6M | $1.9M | ||
| Q2 25 | $-15.1M | $6.2M | ||
| Q1 25 | $19.9M | $5.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | $9.9M | $-1.4M | ||
| Q2 24 | $33.4M | $5.1M | ||
| Q1 24 | $44.9M | $-326.0K |
自由现金流率
IRWD
RGS
| Q4 25 | 156.3% | 1.6% | ||
| Q3 25 | 39.0% | 3.2% | ||
| Q2 25 | -17.7% | 10.3% | ||
| Q1 25 | 48.4% | 10.3% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | 10.8% | -3.0% | ||
| Q2 24 | 35.4% | 10.3% | ||
| Q1 24 | 60.0% | -0.7% |
资本支出强度
IRWD
RGS
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 0.9% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.1% | 0.1% |
现金转化率
IRWD
RGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | 1.19× | 1.68× | ||
| Q2 25 | -0.64× | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | 6.74× | 0.28× | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRWD
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |